CIBC Asset Management
SWTX

CIBC Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

CIBC Asset Management’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-196,912
Closed -$12.5M – 1598
2021
Q3 		$12.5M Buy
196,912
+152
+0.1% +$11.7K 0.05% 203
2021
Q2 		$16.2M Buy
196,760
+90,257
+85% +$6.85M 0.07% 173
2021
Q1 		$7.83M Sell
106,503
-49,480
-32% -$3.87M 0.03% 260
2020
Q4 		$11.3M Buy
155,983
+966
+0.6% +$62.2K 0.05% 199
2020
Q3 		$7.39M Buy
155,017
+29,856
+24% +$1.27M 0.04% 234
2020
Q2 		$5.26M Buy
125,161
+13,895
+12% +$494K 0.03% 256
2020
Q1 		$3M Buy
+111,266
New +$3.63M 0.02% 305

Other funds holding SWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIBC Asset Management's SWTX Position: Q4 2021 in Review

CIBC Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q4 2021, closing a stake of 196,912 shares — an estimated $12.5M sold.

CIBC Asset Management first reported a position in SWTX in Q1 2020 and held it in 7 quarters. The position peaked at $16.2M in Q2 2021. 144 funds tracked by Wall St. Rank hold SWTX as of Q4 2021.

  • CIBC Asset Management reported no remaining SpringWorks Therapeutics position as of Q4 2021 after selling out during the quarter.
  • CIBC Asset Management sold 196,912 SpringWorks Therapeutics shares in Q4 2021, an estimated $12.5M.
  • CIBC Asset Management first reported a position in SpringWorks Therapeutics in Q1 2020 and held it in 7 quarters.
  • CIBC Asset Management's SpringWorks Therapeutics position peaked at $16.2M in Q2 2021.
  • 144 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2021.

Based on CIBC Asset Management's 13F filing for Q4 2021, filed 8 Feb 2022.